School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Scholar Rock Holding Corp SRRK

Healthcare · Biotechnology

$42.19last close 2026-10-09 · market cap $5.14B · delayed data

Trailing returns

1M-22.76%
3M-27.18%
6M-14.23%
1Y+2.93%
5Y+53.36%

Basis: Adjusted daily closes.

What it does

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases.

Open SRRK in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies